Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02204631 · ClinicalTrials.gov registry record · NA

2 Phase Use Of Educational Materials In Head And Neck Cancer Center

A NA study of Head and Neck Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02204631 is a NA study of Head and Neck Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02204631, a NA study of Head and Neck Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess the experience of our patients with head and neck cancer in regard to the information they receive, their symptoms, and their understanding of their diagnosis, to determine ways to improve upon these aspects of patient care in the future.

Conditions Studied

Interventions

  • OTHER Head and Neck Educational Handbook

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2014-08-12
Est. Completion 2016-12-22
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02204631

The ClinicalTrials.gov registry entry for NCT02204631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Head and Neck Educational Handbook is the first listed.

NCT02204631 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02204631 about?

NCT02204631 is a clinical study titled "2 Phase Use Of Educational Materials In Head And Neck Cancer Center". The goal of this study is to assess the experience of our patients with head and neck cancer in regard to the information they receive, their symptoms, and their understanding of their diagnosis, to determine ways to improve upon these aspects of patient care in the future.

What is the current status of trial NCT02204631?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-08-12. Estimated completion is 2016-12-22.

What conditions does trial NCT02204631 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT02204631?

The interventions under investigation include: Head and Neck Educational Handbook (OTHER).

Who is sponsoring clinical trial NCT02204631?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02204631 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.